(%)
Market is Open
Last quote from:
After-Hours Quote
Market is closed for
(%)
After-Hours Quote is Unavailable
Market is Open
Last quote from:
After-Hours Quote
Market is closed for
(%)
After-Hours Quote is Unavailable
- Ownership
-
Kezar Life Sciences, Inc. Executive Compensation
* In original currency USD
Loading Data
|
Filing Date (SEC Report) |
Year | Reporting Name | Salary | Bonus | Stock Award | Incentive Plan Compensation | Other Compensation | Total Amount |
|---|---|---|---|---|---|---|---|---|
| Friday, April 25th, 2025 | 2023 | Marc Belsky Chief Financial Officer | 446,275 | 0 | 0 | 179,938 | 13,200 | 2,006,319 |
| Friday, April 25th, 2025 | 2024 | Marc Belsky Chief Financial Officer | 462,000 | 0 | 0 | 177,408 | 13,800 | 915,043 |
| Friday, April 25th, 2025 | 2023 | Christopher Kirk, Ph.D. Chief Executive Officer | 242,240 | 75,000 | 0 | 47,520 | 279,925 | 2,602,155 |
| Friday, April 25th, 2025 | 2024 | Christopher Kirk, Ph.D. Chief Executive Officer | 600,000 | 0 | 0 | 313,500 | 13,800 | 927,300 |
| Friday, April 25th, 2025 | 2024 | Mark Schiller | 451,000 | 0 | 0 | 173,185 | 13,800 | 868,378 |
| Friday, April 26th, 2024 | 2022 | Christopher Kirk, Ph.D. Chief Executive Officer | 468,000 | 0 | 0 | 196,560 | 12,848 | 2,470,432 |
| Friday, April 26th, 2024 | 2023 | Marc Belsky Chief Financial Officer | 446,275 | 0 | 0 | 179,938 | 13,200 | 2,006,319 |
| Friday, April 26th, 2024 | 2022 | Noreen Roth Henig, M.D. Former Chief Medical Officer | 500,000 | 0 | 0 | 210,000 | 12,848 | 2,621,344 |
| Friday, April 26th, 2024 | 2023 | Noreen Roth Henig, M.D. Former Chief Medical Officer | 404,417 | 0 | 0 | 0 | 196,507 | 2,198,505 |
| Friday, April 26th, 2024 | 2022 | John Fowler Former Chief Executive Officer | 575,000 | 0 | 0 | 332,063 | 12,848 | 6,193,511 |
| Friday, April 26th, 2024 | 2023 | Nick Mordwinkin, Ph.D. | 392,000 | 0 | 0 | 158,054 | 13,200 | 1,763,679 |
| Friday, April 26th, 2024 | 2023 | John Fowler Former Chief Executive Officer | 517,316 | 0 | 0 | 0 | 22,033 | 4,830,882 |
| Friday, April 26th, 2024 | 2023 | Christopher Kirk, Ph.D. Chief Executive Officer | 242,240 | 75,000 | 0 | 47,520 | 279,925 | 2,602,155 |
| Thursday, April 27th, 2023 | 2021 | Noreen Roth Henig, M.D. Chief Medical Officer | 475,000 | 0 | 0 | 218,500 | 12,032 | 1,811,616 |
| Thursday, April 27th, 2023 | 2022 | Noreen Roth Henig, M.D. Chief Medical Officer | 500,000 | 0 | 0 | 210,000 | 12,848 | 2,621,344 |
| Thursday, April 27th, 2023 | 2021 | Christopher Kirk, Ph.D. President and Chief Scientific Officer | 443,000 | 0 | 0 | 203,780 | 12,032 | 1,685,890 |
| Thursday, April 27th, 2023 | 2022 | Christopher Kirk, Ph.D. President and Chief Scientific Officer | 468,000 | 0 | 0 | 196,560 | 12,848 | 2,470,432 |
| Thursday, April 27th, 2023 | 2021 | John Fowler Chief Executive Officer | 567,000 | 0 | 0 | 326,025 | 12,032 | 5,645,417 |
| Thursday, April 27th, 2023 | 2022 | John Fowler Chief Executive Officer | 575,000 | 0 | 0 | 332,063 | 12,848 | 6,193,511 |
| Tuesday, April 26th, 2022 | 2021 | Noreen Roth Henig, M.D. Chief Medical Officer | 475,000 | 0 | 0 | 218,500 | 12,032 | 1,811,616 |
| Tuesday, April 26th, 2022 | 2021 | John Fowler Chief Executive Officer | 567,000 | 0 | 0 | 326,025 | 12,032 | 5,645,417 |
| Tuesday, April 26th, 2022 | 2020 | John Fowler Chief Executive Officer | 546,000 | 0 | 0 | 243,789 | 11,994 | 1,265,683 |
| Tuesday, April 26th, 2022 | 2021 | Christopher Kirk, Ph.D. President and Chief Scientific Officer | 443,000 | 0 | 0 | 203,780 | 12,032 | 1,685,890 |
| Tuesday, April 26th, 2022 | 2020 | Christopher Kirk, Ph.D. President and Chief Scientific Officer | 426,000 | 0 | 0 | 152,167 | 11,994 | 880,099 |
| Tuesday, April 26th, 2022 | 2020 | Noreen Roth Henig, M.D. Chief Medical Officer | 286,667 | 0 | 0 | 174,477 | 11,697 | 1,459,001 |
| Thursday, April 29th, 2021 | 2020 | John Fowler Chief Executive Officer | 546,000 | 0 | 0 | 243,789 | 11,994 | 1,265,683 |
| Thursday, April 29th, 2021 | 2019 | Christopher Kirk, Ph.D. President and Chief Scientific Officer | 410,000 | 0 | 0 | 114,800 | 11,794 | 1,942,334 |
| Thursday, April 29th, 2021 | 2020 | Christopher Kirk, Ph.D. President and Chief Scientific Officer | 426,000 | 0 | 0 | 152,167 | 11,994 | 880,099 |
| Thursday, April 29th, 2021 | 2020 | Noreen Roth Henig, M.D. Chief Medical Officer | 286,667 | 0 | 0 | 174,477 | 11,697 | 1,459,001 |
| Thursday, April 29th, 2021 | 2019 | John Fowler Chief Executive Officer | 525,000 | 0 | 0 | 183,750 | 11,794 | 3,532,024 |
| Wednesday, April 29th, 2020 | 2018 | John Fowler Chief Executive Officer | 460,000 | 0 | 0 | 248,400 | 11,601 | 1,800,543 |
| Wednesday, April 29th, 2020 | 2019 | John Fowler Chief Executive Officer | 525,000 | 0 | 0 | 183,750 | 11,794 | 3,532,024 |
| Wednesday, April 29th, 2020 | 2018 | Niti Goel, M.D. Former Chief Medical Officer | 266,250 | 15,000 | 0 | 86,265 | 11,431 | 1,201,310 |
| Wednesday, April 29th, 2020 | 2019 | Niti Goel, M.D. Former Chief Medical Officer | 309,053 | 0 | 0 | 0 | 614,237 | 2,128,210 |
| Wednesday, April 29th, 2020 | 2018 | Christopher Kirk, Ph.D. President and Chief Scientific Officer | 365,000 | 0 | 0 | 137,970 | 11,601 | 962,353 |
| Wednesday, April 29th, 2020 | 2019 | Christopher Kirk, Ph.D. President and Chief Scientific Officer | 410,000 | 0 | 0 | 114,800 | 11,794 | 1,942,334 |
| Wednesday, April 29th, 2020 | 2019 | Marc Belsky Chief Financial Officer | 375,000 | 0 | 0 | 105,000 | 11,794 | 1,595,872 |
| Tuesday, April 30th, 2019 | 2018 | Christopher Kirk, Ph.D. President and Chief Scientific Officer | 365,000 | 0 | 0 | 137,970 | 11,601 | 962,353 |
| Tuesday, April 30th, 2019 | 2017 | John Fowler Chief Executive Officer | 360,000 | 0 | 0 | 130,000 | 10,800 | 799,276 |
| Tuesday, April 30th, 2019 | 2018 | John Fowler Chief Executive Officer | 460,000 | 0 | 0 | 248,400 | 11,601 | 1,800,543 |
| Tuesday, April 30th, 2019 | 2018 | Niti Goel, M.D. Former Chief Medical Officer | 266,250 | 15,000 | 0 | 86,265 | 11,431 | 1,201,310 |
| Tuesday, April 30th, 2019 | 2017 | Christopher Kirk, Ph.D. President and Chief Scientific Officer | 325,000 | 0 | 0 | 111,000 | 10,800 | 745,276 |
